|

68Ga-RM26 Clinical Trials

2 actively recruiting trials

Also known as: 68Ga-GRPR antagonist, 68Ga-RM26 injection

Pipeline

Early 1: 2

Top Sponsors

  • Peking Union Medical College Hospital2

Indications

  • Cancer2
  • PET/CT Imaging1
  • Glioma1
  • Brain Tumor1
  • Prostate Cancer1

Other2 trials

68Ga-NOTA-RM26 PET/CT in Glioma Patients
Early 1
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.